Next generation of antibody therapy for cancer
Monoclonal antibodies (mAbs) have become a major class of therapeutic agents providing effective alternatives to treating various human diseases. To date, 15 mAbs have been approved by regulatory agencies in the world for clinical use in oncology indications. The selectivity and specificity, the uni...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Sun Yat-sen University Cancer Center
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013394/ |